Drugs / Fecal Microbiota Therapy
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT03005379 Comparator | Nov 2018 → Aug 2022 | Clostridium infectious disease | VA Office of Research and Development | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fecal Microbiota Therapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03005379 ↗ |
| Known as | FMT | “Fecal Microbiota Therapy (FMT)” NCT03005379 ↗ |
| Route | Oral | “Oral capsule-delivered FMT” NCT03005379 ↗ |